CEO & Chairman of the Executive Board Stefan Seuferling leaves the company

RAUMEDIC announces that CEO and Chairman of the Executive Board Stefan Seuferling will leave the company on his own request on March 31, 2025, after six successful years, to pursue new professional challenges.

Significant Contribution to the Group's Success

Stefan Seuferling joined the company in 2018 as a member of the Executive Board. In March 2019, he was appointed Chairman of the Executive Board and Chief Executive Officer of RAUMEDIC AG. Since 2021, he has also served as Chairman of the Supervisory Board of AS RAUMEDIC Estonia, and in 2022, he assumed the role of Chairman of the Board of RAUMEDIC Inc. From July 2024, he additionally led RAUMEDIC Inc. directly as President & CEO.

Under his leadership, the company achieved significant progress in its development and growth, solidifying its position as a leading provider of innovative solutions for the medical technology and pharmaceutical industries.

Stefan Seuferling emphasized: “The decision to leave the company was not an easy one for me. I am proud of what we have achieved together. I would like to thank every single employee for the always constructive and excellent collaboration within such a dedicated and talented team, as well as the Supervisory Board for their support. At the same time, I look forward to my new personal challenge.”

Jürgen Werner, Chairman of the Supervisory Board of RAUMEDIC AG, commented: "On behalf of the Supervisory Board and all its members, I would like to sincerely thank Stefan Seuferling for his work as CEO and his successful leadership of the company over the past six years. We respect Stefan Seuferling's decision and wish him continued success in his personal and professional future."

Focus on Continuity

The company will take the necessary care and time to appoint a successor. Until then, the Executive Board and Supervisory Board will jointly ensure the continuity of the company’s leadership.
RAUMEDIC will provide further information in due course.

The company expresses its gratitude to Stefan Seuferling for his outstanding achievements and wishes him all the best for the future.

About RAUMEDIC

RAUMEDIC develops solutions for life. Together with its customers, the medical and pharmaceutical technology company breaks new ground to improve the diagnosis and therapy of diseases. In doing so, RAUMEDIC focuses on polymer-based solutions for medical and pharmaceutical applications as well as products for intensive care. RAUMEDIC is represented worldwide and employs around 1,200 people at five production sites. In the core markets of Europe and North America, the company manufactures in its own clean room manufacturing facilities.